Binding of vitamin D to VDR resulted in decreased expression of immune checkpoint inhibitors (PD-1, TIGIT, and Tim-3) and increased expression of the co-stimulatory molecule CD28 on CD8+ T cells, which increased their cytokine production and anti-tumor activity [143]. The gene discussed is CD8A; the disease is neoplasm.